Salunkhe, S., Daley, J. M., Kaur, H., Tomimatsu, N., Xue, C., Raina, V. B., Jasper, A. M., Rogers, C. M., Li, W., Zhou, S., Mojidra, R., Kwon, Y., Fang, Q., Ji, J.-H., Badamchi Shabestari, A., Fitzgerald, O., Dinh, H., Mukherjee, B., Habib, A. A., … Sung, P. (2024). Promotion of DNA end resection by BRCA1–BARD1 in homologous recombination. Nature, 634(8033), 482–491. https://doi.org/10.1038/s41586-024-07910-2

Zhu, Y., Pei, X., Novaj, A., Setton, J., Bronder, D., Derakhshan, F., Selenica, P., McDermott, N., Orman, M., Plum, S., Subramanyan, S., Braverman, S. H., McMillan, B., Sinha, S., Ma, J., Gazzo, A., Khan, A., Bakhoum, S., Powell, S. N., … Riaz, N. (2024). Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors. Genome Medicine, 16(1). https://doi.org/10.1186/s13073-024-01371-y

Zanti, M., O’Mahony, D. G., Parsons, M. T., Li, H., Dennis, J., Aittomäkkiki, K., Andrulis, I. L., Anton-Culver, H., Aronson, K. J., Augustinsson, A., Becher, H., Bojesen, S. E., Bolla, M. K., Brenner, H., Brown, M. A., Buys, S. S., Canzian, F., Caputo, S. M., Castelao, J. E., … Michailidou, K. (2023). A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2. Human Mutation, 2023, 1–17. https://doi.org/10.1155/2023/9961341

Trivedi, M. S., & Armstrong, K. A. (2024). Increasing the Uptake of Cancer Risk Management Strategies for Women With BRCA1/2 Sequence Variations. JAMA Oncology, 10(4), 435. https://doi.org/10.1001/jamaoncol.2023.5186

Georgieva, D., Wang, N., Taglialatela, A., Jerabek, S., Reczek, C. R., Lim, P. X., Sung, J., Du, Q., Horiguchi, M., Jasin, M., Ciccia, A., Baer, R., & Egli, D. (2024). BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks. Cell Reports, 43(4), 114006. https://doi.org/10.1016/j.celrep.2024.114006

Yi, H., Trivedi, M. S., Crew, K. D., Schechter, I., Appelbaum, P., Chung, W. K., Allegrante, J. P., & Kukafka, R. (2024). Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community. Public Health Genomics, 57–67. Portico. https://doi.org/10.1159/000536391

Schvartzman, J.-M., Forsyth, G., Walch, H., Chatila, W., Taglialatela, A., Lee, B. J., Zhu, X., Gershik, S., Cimino, F. V., Santella, A., Menghrajani, K., Ciccia, A., Koche, R., Sánchez-Vega, F., Zha, S., & Thompson, C. B. (2023). Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination. Molecular Cell, 83(13), 2347-2356.e8. https://doi.org/10.1016/j.molcel.2023.05.026

Huepenbecker, S. P., Wright, J. D., Downer, M. K., Incerti, D., Luhn, P., Dolado, I., Bastiere-Truchot, L., Lin, Y. G., Chan, J. K., & Meyer, L. A. (2022). Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer. Obstetrics & Gynecology, 140(5), 758–767. https://doi.org/10.1097/aog.0000000000004958

Park, D., Gharghabi, M., Reczek, C. R., Plow, R., Yungvirt, C., Aldaz, C. M., & Huebner, K. (2022). Wwox Binding to the Murine Brca1-BRCT Domain Regulates Timing of Brip1 and CtIP Phospho-Protein Interactions with This Domain at DNA Double-Strand Breaks, and Repair Pathway Choice. International Journal of Molecular Sciences, 23(7), 3729. https://doi.org/10.3390/ijms23073729

Lin, P.-H., Chen, S.-C., Tseng, L.-M., Chang, K.-J., Huang, A.-C., Cheng, K.-C., Yang, K., Wu, H.-C., Chao, T.-Y., Chang, Y.-C., Lin, P.-C., Kuo, W.-H., Kuo, W.-L., Lin, C.-H., Chen, H.-M., Yeh, D.-C., Liu, L.-C., Liu, C.-Y., Wang, M.-Y., … Huang, C.-S. (2022). Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients. Breast Cancer Research and Treatment, 192(3), 629–637. https://doi.org/10.1007/s10549-021-06446-7

Küry, S., Ebstein, F., Mollé, A., Besnard, T., Lee, M.-K., Vignard, V., Hery, T., Nizon, M., Mancini, G. M. S., Giltay, J. C., Cogné, B., McWalter, K., Deb, W., Mor-Shaked, H., Li, H., Schnur, R. E., Wentzensen, I. M., Denommé-Pichon, A.-S., Fourgeux, C., … Isidor, B. (2022). Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder. The American Journal of Human Genetics, 109(2), 361–372. https://doi.org/10.1016/j.ajhg.2021.12.011